218 related articles for article (PubMed ID: 3121748)
81. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
82. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
[TBL] [Abstract][Full Text] [Related]
83. Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma-interferon supplemented with lipopolysaccharide or muramyldipeptide.
Stukart MJ; Rijnsent A; Roos E
Cancer Res; 1987 Jul; 47(14):3880-5. PubMed ID: 3109735
[TBL] [Abstract][Full Text] [Related]
84. Activation of mouse macrophages for migration inhibition and for tumor cytotoxicity is mediated by interferon-gamma priming and triggering by various agents.
Herriott MJ; Leu RW
J Interferon Res; 1987 Apr; 7(2):165-71. PubMed ID: 3112246
[TBL] [Abstract][Full Text] [Related]
85. Priming and triggering of tumoricidal and schistosomulicidal macrophages by two sequential lymphokine signals: interferon-gamma and macrophage cytotoxicity inducing factor 2.
Krammer PH; Kubelka CF; Falk W; Ruppel A
J Immunol; 1985 Nov; 135(5):3258-63. PubMed ID: 3930600
[TBL] [Abstract][Full Text] [Related]
86. Establishment of murine macrophage hybridoma clones capable of acquiring tumoricidal activity upon activation with recombinant interferon-gamma and lipopolysaccharide.
Kiyotaki C; Katagiri T; Tatsumi Y; Fujiwara H; Hamaoka T
J Cancer Res Clin Oncol; 1987; 113(4):383-6. PubMed ID: 3110175
[TBL] [Abstract][Full Text] [Related]
87. In vitro activation of tumoricidal properties of rat peritoneal macrophages using lipopolysaccharide.
Kalafut F; Kusenda J; Klobusická M; Novotná L
Neoplasma; 1990; 37(4):405-14. PubMed ID: 2234202
[TBL] [Abstract][Full Text] [Related]
88. Alteration of in vitro murine peritoneal macrophage function by dietary enrichment with eicosapentaenoic and docosahexaenoic acids in menhaden fish oil.
Somers SD; Chapkin RS; Erickson KL
Cell Immunol; 1989 Oct; 123(1):201-11. PubMed ID: 2550148
[TBL] [Abstract][Full Text] [Related]
89. Augmentation by bacterial lipopolysaccharide of antitumor potency of murine recombinant interferon-gamma against Lewis lung adenocarcinoma.
Nagao S; Sato K; Ogawa H; Osada Y
Jpn J Cancer Res; 1986 Feb; 77(2):212-8. PubMed ID: 3082834
[TBL] [Abstract][Full Text] [Related]
90. Modulation of macrophage-mediated tumoricidal activity by neuropeptides and neurohormones.
Koff WC; Dunegan MA
J Immunol; 1985 Jul; 135(1):350-4. PubMed ID: 2582037
[TBL] [Abstract][Full Text] [Related]
91. Studies on chemiluminescence and protein kinase-C activity of cisplatin treated mouse peritoneal exudate cells.
Geetha B; Sodhi A; Singh SM
Immunopharmacol Immunotoxicol; 1991; 13(1-2):1-10. PubMed ID: 1770212
[TBL] [Abstract][Full Text] [Related]
92. Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages.
Van Lenten BJ; Fogelman AM; Seager J; Ribi E; Haberland ME; Edwards PA
J Immunol; 1985 Jun; 134(6):3718-21. PubMed ID: 2985693
[TBL] [Abstract][Full Text] [Related]
93. Synergistic interactions between IFN-gamma and IFN-beta in priming murine macrophages for tumor cell killing.
Pace JL
J Leukoc Biol; 1988 Dec; 44(6):514-20. PubMed ID: 3142957
[TBL] [Abstract][Full Text] [Related]
94. Role of macrophage lipids in regulating tumoricidal activity. II. Internal genetic and external physiologic regulatory factors controlling macrophage tumor cytotoxicity also control characteristic lipid changes associated with tumoricidal cells.
Schlager SI; Meltzer MS
Cell Immunol; 1983 Aug; 80(1):10-9. PubMed ID: 6872005
[TBL] [Abstract][Full Text] [Related]
95. Effect of cisplatin and other biological response modifiers on the activity of lysozyme, plasminogen activator and 5' nucleotidase by murine macrophages in vitro.
Geetha B; Sodhi A
Biochem Int; 1990 Dec; 22(6):1103-14. PubMed ID: 2128598
[TBL] [Abstract][Full Text] [Related]
96. Lipopolysaccharide and polyribonucleotide activation of macrophages: implications for a natural triggering signal in tumor cell killing.
Torres BA; Johnson HM
Biochem Biophys Res Commun; 1985 Aug; 131(1):395-401. PubMed ID: 3929779
[TBL] [Abstract][Full Text] [Related]
97. Synthesis of nitrite and nitrate in murine macrophage cell lines.
Stuehr DJ; Marletta MA
Cancer Res; 1987 Nov; 47(21):5590-4. PubMed ID: 3117354
[TBL] [Abstract][Full Text] [Related]
98. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol.
Burnette-Curley D; Cabral GA
Proc Soc Exp Biol Med; 1995 Oct; 210(1):64-76. PubMed ID: 7675800
[TBL] [Abstract][Full Text] [Related]
99. Growth inhibition of tumour cells by a liposome-encapsulated, mycolic acid-containing glycolipid, trehalose 2,3,6'-trimycolate.
Ohtsubo Y; Furukawa M; Imagawa T; Sugimoto N; Ikutoh M; Nakatsugi S; Katoh Y; Shinka S; Dohi Y
Immunology; 1991 Nov; 74(3):497-503. PubMed ID: 1769697
[TBL] [Abstract][Full Text] [Related]
100. Activation of murine macrophages by tumor necrosis factor, interleukin-1, interferon-gamma and cisplatin.
Sodhi A; Singh RK; Pai K
Immunol Lett; 1990 Oct; 26(1):45-50. PubMed ID: 2125975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
